Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Unknown × Carcinoma, Medullary × Clear all

Phase

Phase 1/2 3 Phase 2 2 Phase NA 1 Phase 4 1 Phase 3 1

Status

Unknown 1 Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 45 Carcinoma, Hepatocellular 37 Neoplasms 36 Polycystic Ovary Syndrome 23 Colorectal Neoplasms 23 Stomach Neoplasms 19 Prostatic Neoplasms 15 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Carcinoma, Non-Small-Cell Lung 15 Recurrence 13 Pancreatic Neoplasms 12 Lymphoma 11 Liver Neoplasms 11 Leukemia, Myeloid, Acute 11 Esophageal Neoplasms 11 Leiomyoma 10 Urinary Bladder Neoplasms 9 Colonic Neoplasms 9 Pain 8 Lung Neoplasms 8 Uterine Cervical Neoplasms 7 Pain, Postoperative 6 Neoplasm Metastasis 6 Multiple Myeloma 6 Lymphoma, Follicular 6 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Keratosis, Actinic 6 Infertility 6 Neutropenia 5 NSCLC 5

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01915485 2016-09-07

Radiolabeled Molecules for Medullary Thyroid Cancer

Instituto Nacional de Cancer, Brazil

Phase 4 Unknown

Carcinoma, Medullary

Data powered by HemOnc (CC BY 4.0) Colophon ⚡